Clearside Biomedical Inc
NASDAQ:CLSD

  • LAST PRICE
    1.3500
  • TODAY'S CHANGE (%)
    0.0800 (6.2992%)
  • Bid / Lots
    1.2900/ 1
  • Ask / Lots
    1.3600/ 67
  • Open / Previous Close
    1.2900 / 1.2700
  • Day Range
    1.2500
    1.3600
  • 52 Week Range
    0.6501
    2.1200
  • Volume
    133,278

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

      Show headlines and story abstract

    • 1 hour ago by GlobeNewswire
      Companies Mentioned: CLSD

    • 1 hour ago by Dow Jones
      Companies Mentioned: CLSD

      -Financial Tables Follow-
      CLEARSIDE BIOMEDICAL, INC. Selected Financial Data (in thousands, except share and per share data) (unaudited) Three Months Ended Statements of Operations Data March 31, ------------------------- 2024 2023 ----------- ----------- License and other revenue $ 230 $ 4 Operating expenses: Research and development 5,615 4,451 General and administrative 2,824 3,158 ---------- ---------- Total operating expenses 8,439 7,609 ---------- ---------- Loss from operations (8,209) (7,605) Interest income 348 492 Other expense (1,499) -- Non-cash interest expense on liability related to the sales of future royalties (2,403) (2,167) ---------- ---------- Net loss $ (11,763) $ (9,280) ========== ========== Net loss per share of common stock -- basic and diluted $ (0.17) $ (0.15) ========== ========== Weighted average shares outstanding -- basic and diluted 69,853,227 61,169,486 ========== ========== Balance Sheet Data March 31, December 31, 2024 2023 ----------- -------------- Cash and cash equivalents $ 35,355 $ 28,920 Total assets 40,142 34,018 Liabilities related to the sales of future royalties, net 44,391 41,988 Warrant liabilities 11,039 -- Total liabilities 61,952 49,930 Total stockholders' deficit (21,810 ) (15,912 )

    • 1 hour ago by Dow Jones
      Companies Mentioned: CLSD

      -Financial Tables Follow-
      CLEARSIDE BIOMEDICAL, INC. Selected Financial Data (in thousands, except share and per share data) (unaudited) Three Months Ended Statements of Operations Data March 31, ------------------------- 2024 2023 ----------- ----------- License and other revenue $ 230 $ 4 Operating expenses: Research and development 5,615 4,451 General and administrative 2,824 3,158 ---------- ---------- Total operating expenses 8,439 7,609 ---------- ---------- Loss from operations (8,209) (7,605) Interest income 348 492 Other expense (1,499) -- Non-cash interest expense on liability related to the sales of future royalties (2,403) (2,167) ---------- ---------- Net loss $ (11,763) $ (9,280) ========== ========== Net loss per share of common stock -- basic and diluted $ (0.17) $ (0.15) ========== ========== Weighted average shares outstanding -- basic and diluted 69,853,227 61,169,486 ========== ========== Balance Sheet Data March 31, December 31, 2024 2023 ----------- -------------- Cash and cash equivalents $ 35,355 $ 28,920 Total assets 40,142 34,018 Liabilities related to the sales of future royalties, net 44,391 41,988 Warrant liabilities 11,039 -- Total liabilities 61,952 49,930 Total stockholders' deficit (21,810 ) (15,912 )

  • Yesterday

Peers Headlines